Nigella sativa Relieves the Altered Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats Fed with a High-Fat Diet

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Balbaa, Mahmoud ^a   El Zeftawy, Marwa ^b   Ghareeb, Doaa ^a   Taha, Nabil ^b   Mandour, Abdel Wahab ^b  

^a Alexandria University Faculty Of Science   (Egypt)

^b Alexandria University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; GENES; GLUCOSE; INSULIN; RATS;

ANTIDIABETIC ACTIVITY; BLOOD GLUCOSE LEVEL; INSULIN RECEPTORS; INSULIN-LIKE GROWTH FACTOR-1; PHARMACOLOGICAL ACTIVITY; PHOSPHOINOSITIDES; SIGNALING MOLECULES; TUMOR NECROSIS FACTORS;

GENE EXPRESSION;

ANTIDIABETIC AGENT; BETA ACTIN; GLIMEPIRIDE; GLUCOSE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE RECEPTOR BLOCKING AGENT; I OME AG538; INSULIN; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NIGELLA SATIVA OIL; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; INSR PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BLACK CUMIN; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HISTOLOGY; INSULIN RESISTANCE; LIPID DIET; LIVER CELL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; MALE; NIGELLA SATIVA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN;

EID: 84984891035     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/2492107     Document Type: Article

References (69)

1. J. Ventura-Sobrevilla, V. D. Boone-Villa, C. N. Aguilar et al., "Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice, " Proceedings of the Western Pharmacology Society, vol. 54, pp. 5-9, 2011.
2. T. Tuomi, "Type 1 and type 2 diabetes: what do they have in common?" Diabetes, vol. 54, no. 2, pp. S40-S45, 2005.
3. A. Sachin, K. O. Shreesh, and V. Divya, "Characterization of streptozotocin induced diabetes mellitus in Swiss albino mice, " Global Journal of Pharmacology, vol. 3, no. 2, pp. 81-84, 2009.
4. A. Zorzano, W. Wilkinson, N. Kotliar et al., "Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations, "The Journal of Biological Chemistry, vol. 264, no. 21, pp. 12358-12363, 1989.
5. A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri, "Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease, " Endocrine Reviews, vol. 30, no. 6, pp. 586-623, 2009.
6. G. Charpentier, F. Fleury, M. Kabir, L. Vaur, and S. Halimi, "Improved glycemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients, " Diabetic Medicine, vol. 18, no. 10, pp. 828-834, 2001.
7. T. A. Gaziano, G. Galea, and K. S. Reddy, "Scaling up interventions for chronic disease prevention: The evidence, " The Lancet, vol. 370, no. 9603, pp. 1939-1946, 2007.
8. C. C. Woo, S. Y. Loo, V. Gee et al., "Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-pathway, " Biochemical Pharmacology, vol. 82, no. 5, pp.464-475, 2011.
9. A.-M. M. Fouda, M.-H. Y. Daba, G. M. Dahab, and O. A. Sharaf El-Din, "Thymoquinone ameliorates renal oxidative damage and proliferative response induced bymercuric chloride in rats, " Basic and Clinical Pharmacology and Toxicology, vol. 103, no. 2, pp. 109-118, 2008.
10. O. A. Badary, M. F. Abd-Ellah, M. A. El-Mahdy, S. A. Salama, and F. M. Hamada, "Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice, " Food and Chemical Toxicology, vol. 45, no. 1, pp. 88-92, 2007.
11. H. Gali-Muhtasib, A. Roessner, and R. Schneider-Stock, "Thymoquinone: A promising anti-cancer drug from natural sources, " The International Journal of Biochemistry and Cell Biology, vol. 38, no. 8, pp. 1249-1253, 2006.
12. H. Hosseinzadeh and S. Parvardeh, "Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice, " Phytomedicine, vol. 11, no. 1, pp. 56-64, 2004.
13. B. Meddah, R. Ducroc, M. El Abbes Faouzi et al., "Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats, " Journal of Ethnopharmacology, vol. 121, no. 3, pp. 419-424, 2009.
14. M. R. Mahmoud, H. S. El-Abhar, and S. Saleh, "The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice, " Journal of Ethnopharmacology, vol. 79, no. 1, pp. 1-11, 2002.
15. S. M. K. Swamy and B. K. H. Tan, "Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds, " Journal of Ethnopharmacology, vol. 70, no. 1, pp. 1-7, 2000.
16. K. Srinivasan, P. S. Patole, C. L. Kaul, and P. Ramarao, "Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats, " Methods and Findings in Experimental and Clinical Pharmacology, vol. 26, no. 5, pp. 327-333, 2004.
17. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, "Combination of high-fat diet-fed and low-dose streptozotocintreated rat: A model for type 2 diabetes and pharmacological screening, " Pharmacological Research, vol. 52, no. 4, pp. 313-320, 2005.
18. A.H. Rahman and S. Venkatraman, "Evaluation of anti-diabetic activity of Picrorhiza scrophulariiflora Pennell in high fat fed diet with streptozotocin induced type II diabetic rats, " International Journal of Pharmaceutical Sciences and Research, vol. 2, no. 7, pp. 1829-1835, 2011.
19. D. Kianifard, R. A. Sadrkhanlou, and S. Hasanzadeh, "The histological, histomorphometrical and histochemical changes of testicular tissue in the metformin treated and untreated streptozotocin-induced adult diabetic rats, " Veterinary Research Forum, vol. 2, no. 1, pp. 13-24, 2011.
20. G. Blum, A. Gazit, and A. Levitzki, "Substrate competitive inhibitors of IGF-1 receptor kinase, " Biochemistry, vol. 39, no. 51, pp. 15705-15712, 2000.
21. L. de Barros Leite Albuquerque, C. A. Dal Belo, M. G. dos Santos, P. S. Lopes, M. Gerenutti, and Y. Oshima-Franco, "Assessment of cytotoxicity, fetotoxicity, and teratogenicity of Plathymenia reticulata benth barks aqueous extract, " BioMed Research International, vol. 2013, Article ID 128594, 8 pages, 2013.
22. M. F. Altan, M. Kanter, S. Donmez, M. E. Kartal, and S. Buyukbas, "Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats, " Acta Histochemica, vol. 109, no. 4, pp. 304-314, 2007.
23. P. Trinder, "Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor, " Annals of Clinical Biochemistry, vol. 6, no. 1, pp. 24-33, 1969.
24. B. T. Doumas, D. D. Bayse, R. J. Carter, T. Peters Jr., and R. Schaffer, "A candidate reference method for determination of total protein in serum. I. Development and validation, " Clinical Chemistry, vol. 27, no. 10, pp. 1642-1650, 1981.
25. P. C. Kao, R. L. Taylor, and F. J. Service, "Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma, " The Journal of Clinical Endocrinology andMetabolism, vol. 78, no. 5, pp. 1048-1051, 1994.
26. A. Salama, W. Ibrahim, T. El-Nimr, M. A. Abd El-, and E. Tousson, "Effect ofmyrrh extract (Mirazid-) on experimentally diabetic rats, " Pharmacologia, vol. 5, no. 4, pp. 135-142, 2014.
27. H. M. Flegg, "An investigation of the determination of serum cholesterol by an enzymatic method, " Annals of Clinical Biochemistry, vol. 10, no. 1-6, pp. 79-84, 1973.
28. G. Bucolo and H. David, "Quantitative determination of serum triglycerides by the use of enzymes, " Clinical Chemistry, vol. 19, no. 5, pp. 476-482, 1973.
29. A. M. Gotto Jr., "Lipoprotein metabolism and the etiology of hyperlipidemia, " Hospital Practice, vol. 23, no. 1, pp. 4-13, 1988.
30. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, " Clinical Chemistry, vol. 18, no. 6, pp. 499-502, 1972.
31. A. Hakim, A. Mittal, and S. Das, "Study of the antihyperlipidemic, anioxidative and anti-Atherogenic activity of Aegle marmelos Linn. in rabbit receiving high fat diet, " Asian Journal of Pharmaceutical and Clinical Research, vol. 5, no. 4, pp. 69-72, 2012.
32. A. Lukaszewicz-Hussain, J. Moniuszko-Jakoniuk, and J. Rogalska, "Assessment of lipid peroxidation in rat tissues in subacute chlorfenvinphos administration, " Polish Journal of Environmental Studies, vol. 16, no. 2, pp. 233-236, 2007.
33. A. L. Tappel and H. Zalkin, "Inhibition of lipide peroxidation in mitochondria by vitamin E, " Archives of Biochemistry and Biophysics, vol. 80, no. 2, pp. 333-336, 1959.
34. K. Menaka, A. Ramesh, B. Thomas, andN. Kumari, "Estimation of nitric oxide as an inflammatory marker in periodontitis, " Journal of Indian Society of Periodontology, vol. 13, no. 2, pp. 75-78, 2009.
35. P. O. Okonkwo and Z. S. C. Okoye, "Comparative effects of antidiabetic drug, metformin and deferoxamine, on serum lipids, serum ferritin and endocrine indicators of diabetes mellitus complications in sreptozotocin diabetic rats, " International Journal of BiochemistryResearch&Review, vol. 4, no.6, pp. 536-549, 2014.
36. M. I. Saad, M. A. Kamel, M. Y. Hanafi, M. H. Helmy, andR. Shehata, "Effect of sitagliptin and glimepiride on glucose homeostasis and cAMP levels in peripheral tissues of HFD/STZ diabetic rats, " American Journal of Biomedical Research, vol. 2, no. 3, pp. 52-60, 2014.
37. O. Paulina, A. Rasaki, and A. Veronica, "Effect of raw and cooked ginger (Zingiber officinale) extracts on serum insulin in normal and diabetic rats, " International Journal of Clinical Nutrition, vol. 2, no. 4, pp. 69-73, 2014.
38. L.H. Storlien, D. A. Pan, A. D. Kriketos et al., "Skeletalmuscle membrane lipids and insulin resistance, " Lipids, vol. 31, no. 1, pp. S261-S265, 1996.
39. B. Ozel, J. F. Youngren, J. K. Kim, I. D. Goldfine, C. K. Sung, and J. H. Youn, "The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity ormembrane glycoprotein PC-1, " Biochemical and Molecular Medicine, vol. 59, no. 2, pp. 174-181, 1996.
40. T. J. Chahil and H. N. Ginsberg, "Diabetic dyslipidemia, " Endocrinology andMetabolismClinics of North America, vol. 35, no. 3, pp. 491-510, 2006.
41. A. D. Mooradian, "Dyslipidemia in type 2 diabetes mellitus, " Nature Clinical Practice Endocrinology &Metabolism, vol. 5, no. 3, pp. 150-159, 2009.
42. K. N. Frayn, "Adipose tissue and the insulin resistance syndrome, " Proceedings of the Nutrition Society, vol. 60, no. 3, pp. 375-380, 2001.
43. A. D. Mooradian, M. J. Haas, K. R. Wehmeier, and N. C. W. Wong, "Obesity-related changes in high-density lipoprotein metabolism, " Obesity, vol. 16, no. 6, pp. 1152-1160, 2008.
44. A. Gidado, D. A. Ameh, S. E. Atawodi, and S. Ibrahim, "Hypoglycaemic activity ofNauclea latifolia sm. (Rubiaceae) in experimental animals, " African Journal of Traditional, Complementary and Alternative Medicines, vol. 5, no. 2, pp. 201-208, 2008.
45. E. Shafrir, "Diabetes in animals: contribution to the understanding of diabetes by study of its etiopathology in animal models, " in DiabetesMellitus, D. Porte, R. S. Sherwin, andA. Baron, Eds., pp. 231-255, McGraw-Hill, NewYork, NY, USA, 2003.
46. O. E. Yakubu, E. Ojogbane, O. F. C. Nwodo, V. O. Nwaneri-Chidozie, andM. N. Ugwu, "Study of lipid profile and lipid peroxide in diabetes mellitus treated with Vitex donianaethanol leaf extract, " European Journal of Experimental Biology, vol. 3, no. 3, pp. 624-629, 2013.
47. M. Kaleem, D. Kirmani, M. Asif, Q. Ahmed, and B. Bano, "Biochemical effects of Nigella sativa L seeds in diabetic rats, " Indian Journal of Experimental Biology, vol. 44, no. 9, pp. 745-748, 2006.
48. Y. Kocyigit, Y. Atamer, and E. Uysal, "The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats, " Saudi Medical Journal, vol. 30, no. 7, pp. 893-896, 2009.
49. A. Virkamäki, K. Ueki, and C. R. Kahn, "Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance, "The Journal of Clinical Investigation, vol. 103, no. 7, pp. 931-943, 1999.
50. K. Hojlund, "Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance, " Danish Medical Journal, vol. 61, no. 7, Article IDB4890, 2014.
51. S. J. Robins, "Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?" Current Opinion in Lipidology, vol. 14, no. 6, pp. 575-583, 2003.
52. M. Anai, M. Funaki, T. Ogihara et al., "Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats, " Diabetes, vol. 47, no. 1, pp. 13-23, 1998.
53. D. E. Moller, "New drug targets for type 2 diabetes and the metabolic syndrome, " Nature, vol. 414, no. 6865, pp. 821-827, 2001.
54. M. Garg, R. Kiran, and D. D. Bansal, "High sucrose low magnesium diet modulates the expression of PI3K and ERK2 in different tissues of weanling rats, " American Journal of Biomedical Sciences, vol. 3, no. 1, pp. 11-22, 2011.
55. G. Boden, "Obesity and free fatty acids, " Endocrinology and MetabolismClinics of North America, vol. 37, no. 3, pp. 635-646, 2008.
56. H.-D. Yuan and S.-H. Chung, "Protective effects of fermented ginseng on streptozotocin-induced pancreatic-cell damage through inhibition ofNF-B, " International Journal ofMolecular Medicine, vol. 25, no. 1, pp. 53-58, 2010.
57. M. Federici, R. Menghini, A. Mauriello et al., "Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells, " Circulation, vol. 106, no. 4, pp. 466-472, 2002.
58. R. Menghini, S. Menini, R. Amoruso et al., "Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice, " Gastroenterology, vol. 136, no. 2, pp. 663-672.e4, 2009.
59. L. Rui, V. Aguirre, J. K. Kim et al., "Insulin/IGF-1 and TNF-stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways, "The Journal of Clinical Investigation, vol. 107, no. 2, pp. 181-189, 2001.
60. N. T. Niture, A. A. Ansari, and S. R. Naik, "Anti-hyperglycemic activity of Rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines, antioxidants and lipid biomarkers, " Indian Journal of Experimental Biology, vol. 52, no. 7, pp. 720-727, 2014.
61. A. M. Saud, "Serum levels of tumor necrosis factor alpha and interleukin-12 in some Iraqi diabetic patients type I, " International Journal of Current Microbiology and Applied Science, vol. 3, no. 4, pp. 260-268, 2014.
62. M. Bartoli, F. Lamoke, S. Shaw, D. Gutsaeva, and B. Baban, "Modulation of cytokine trans-signaling by microRNA-21 (miR-21)-mediated regulation of TACE/ADAM17 in the diabetic retina, " Investigative Ophthalmology and Visual Science, vol. 55, no. 13, p. 1030, 2014.
63. R. Nahta, L. X. H. Yuan, B. Zhang, R. Kobayashi, and F. J. Esteva, "Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells, " Cancer Research, vol. 65, no. 23, pp. 11118-11128, 2005.
64. P. M. Le, A. Benhaddou-Andaloussi, A. Elimadi, A. Settaf, Y. Cherrah, and P. S. Haddad, "The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat, " Journal of Ethnopharmacology, vol. 94, no. 2-3, pp. 251-259, 2004.
65. N. Houstis, E. D. Rosen, and E. S. Lander, "Reactive oxygen species have a causal role in multiple forms of insulin resistance, " Nature, vol. 440, no. 7086, pp. 944-948, 2006.
66. F. Song, W. Jia, Y. Yao et al., "Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes, " Clinical Science, vol. 112, no. 12, pp. 599-606, 2007.
67. Q. Wang, R. Somwar, P. J. Bilan et al., "Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts, " Molecular and Cellular Biology, vol. 19, no. 6, pp. 4008-4018, 1999.
68. S. Mamta and K. Preeti, "Interacting effect of co-Administration of Urtica dioica leaf extract with two oral antidiabetic agents (glimepiride and metformin) in streptozotocin and DNA induced diabetic rats, " International Journal of Universal Pharmacy and Biosciences, vol. 2, no. 6, pp. 326-335, 2013.
69. T. Poonam, G. P. Prakash, and L. V. Kumar, "Interaction of Momordica Charantia with metformin in diabetic rats, " American Journal of Pharmacology and Toxicology, vol. 8, no. 3, pp. 102-106, 2013.